Trending News

#Collaboration #Drug discovery

This week in drug discovery (7-11 February) 

News round-up by DDW’s Megan Thomas for 7-11 February, 2022  This week has proved eventful in terms of progression in the drug discovery industry. DDW’s Megan Thomas flags five news stories which display this.  1. Additional dose of Covid-19 vaccine is safe, says US trial … Read More

#News #Trending News

#Biotechnology #Drug discovery #eBook #Lab automation

eBook: Your essential guide to drug discovery technology

This 28-page DDW eBook, sponsored by Bio-Rad, contains exclusive insight from industry experts on what’s new in lab automation and how this technology can accelerate your drug discovery process and is available to download now. With this guide, you can learn more about: The benefits of automation and how to… Read More

#News #Trending News

#Covid booster #Covid variants #Covid-19 #Immunology / Virology & Vaccines #Moderna #mRNA #Omicron

Moderna begins Omicron booster trial and presents durability data 

Moderna has dosed the first participant in a Phase II study of the company’s Omicron-specific booster candidate (mRNA-1273.529). Additionally, Moderna announced the publication of neutralising antibody data against the Omicron variant six months following a booster dose in The New England Journal of Medicine.   The mRNA-1273.529 trial  This extension… Read More

#News #Trending News

#Life sciences #SLAS2022

Highlights from SLAS2022

DDW’s Megan Thomas rounds up some highlights from SLAS2022 which took place in Boston, US. Lab design from the future This event marked the start of DDW’s Megan Thomas’ day at SLAS2022, which was chaired by MOMA Therapeutics’ Katelyn Hardy. The session started with Hardy presenting, “How to position your… Read More

#News #Trending News

#Covid booster #Covid-19 #FDA #Immunology / Virology & Vaccines #mRNA

Additional dose of Covid-19 vaccine is safe, says US trial 

A study sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, suggests that an additional dose of a Covid-19 vaccine is safe in adults who had previously received a full regimen of any of three Covid-19 vaccines granted Emergency Use Authorization… Read More

#News #Trending News

Human liver
#Clinical trials #Liver disease #Oncology #Therapeutics #Tumours

First patient dosed in advanced liver cancer clinical trial 

MiNA Therapeutics has dosed the first patient in a global Phase II clinical trial (OUTREACH-2) of MTL-CEBPA in combination with second line standard of care sorafenib (a tyrosine kinase inhibitor (TKI)) in advanced hepatocellular carcinoma (HCC or liver cancer).  What is OUTREACH-2?  OUTREACH-2 is a multi-centre,… Read More

#News #Trending News

#Genome sequencing #Genomics #Podcasts

Podcast: What can we learn from the genome?  

This is the latest episode of the free DDW podcast, “What can we learn from the genome?”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW and read aloud by Megan Thomas.   The articles are called “Reproducibility in single cell… Read More

#News #Trending News

#Assays #Biotechnology #Drug discovery #Enzymes #TechNote

TechNote: Radioactivity assays for methyltransferase enzymes

In this free TechNote by SAMDI Tech, learn how the company’s radioactivity assays overcome key challenges in drug discovery by offering key solutions, including: Detecting low amounts of product with sensitive assays Generating data rapidly with high-throughput, 384-well capabilities Characterising potent inhibitors by benefiting from lower enzyme concentrations Learn… Read More

#News #Trending News

#Cancer immunotherapy #Immunotherapy #Liver disease #Oncology

Immunotherapy before surgery in liver cancer patients can kill the tumour  

In a clinical trial, Mount Sinai scientists gave immunotherapy to liver cancer patients before they received surgery and found that tumours died off significantly before surgery in a third of the patients, according to results reported in The Lancet Gastroenterology and Hepatology.   The results  The researchers… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Informatics #Laboratory data #Public health

Combined group to improve outcomes in diagnostics and lab informatics  

CliniSys has acquired Horizon Lab Systems and combined with Sunquest Information Systems, to create an organisation dedicated to diagnostic and laboratory informatics.  Outlook  CliniSys’ vision is to embrace a new wave of digital diagnostics and laboratories across the continuum of care and community to improve public health.  Horizon… Read More

#News #Trending News

#Drug discovery #Events #Lab automation #SLAS2022

What to expect from SLAS2022 

SLAS2022 in Boston is moving ahead as an in-person event with a hybrid component from February 5-9, 2022 at Boston Convention & Exhibition Center, which unsurprisingly has many from the drug discovery industry excited, including the DDW team, who will be stationed at Booth 1945.   DDW has teamed up with SLAS to… Read More

#Exclusive Content #News #Trending News

#Drug discovery

This week in drug discovery (17-21 January) 

News round-up by DDW’s Megan Thomas for 17-21 January, 2022  When it comes to drug discovery and development, it’s all about the research, the breakthroughs and the next step. DDW’s Megan Thomas has rounded up five stories which highlight this theme of progress.  1. Read More

#News #Trending News

#Biotechnology #Drug discovery #Therapeutics

Drug discovery movers: who’s going where? 

The new year is underway and with it comes a raft of movement within some of the industry’s key businesses. DDW’s Megan Thomas rounds up seven new additions to the sector.  Dr Charles Woler (Sygnature Discovery, UK)  Sygnature Discovery, provider of drug discovery solutions, has appointed Dr Charles Woler as Chairman. Dr Woler has… Read More

#News #Trending News

Lung cancer
#AstraZeneca #Lung cancer #Oncology

Success for AstraZeneca lung cancer therapy 

AstraZeneca’s Tagrisso (osimertinib) has been accepted for use within NHS Scotland by the Scottish Medicines Consortium (SMC) as monotherapy for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.1  Context  Lung… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Drug discovery

DDW exclusive: 2022 drug discovery challenges and opportunities 

DDW’s Megan Thomas spoke to key decision-makers from the drug discovery industry about their predictions on what 2022 holds for our sector, which can be downloaded and viewed for free from the DDW App for users of Apple or Android devices. “Carefully distinguishing true opportunities from passing fads will… Read More

#News #Trending News

#Drug discovery #Pharmaceuticals

Pharmaceutical executive takes the Synature Discovery reins 

Sygnature Discovery, providers of drug discovery solutions, has appointed Dr Charles Woler as Chairman.  Woler’s career Dr Woler has held multiple key roles in the sector, including CEO at Roche France, Executive Chairman for Europe at SmithKline Beecham, and CEO at Cadus Pharmaceutical in the US.   Official comments … Read More

#News #Trending News